NO996049L - Farmasoeytisk preparat med kontrollert frigjoering, med ACE- inhibitor som aktiv ingrediens - Google Patents

Farmasoeytisk preparat med kontrollert frigjoering, med ACE- inhibitor som aktiv ingrediens

Info

Publication number
NO996049L
NO996049L NO996049A NO996049A NO996049L NO 996049 L NO996049 L NO 996049L NO 996049 A NO996049 A NO 996049A NO 996049 A NO996049 A NO 996049A NO 996049 L NO996049 L NO 996049L
Authority
NO
Norway
Prior art keywords
active ingredient
ace inhibitor
controlled release
pharmaceutical preparation
release pharmaceutical
Prior art date
Application number
NO996049A
Other languages
English (en)
Norwegian (no)
Other versions
NO996049D0 (no
Inventor
Wilfried Fischer
Karin Klokkers
Renate Oppelt
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of NO996049D0 publication Critical patent/NO996049D0/no
Publication of NO996049L publication Critical patent/NO996049L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO996049A 1997-06-12 1999-12-08 Farmasoeytisk preparat med kontrollert frigjoering, med ACE- inhibitor som aktiv ingrediens NO996049L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19724696A DE19724696A1 (de) 1997-06-12 1997-06-12 Pharmazeutische Zubereitung mit drei Pelletarten
PCT/EP1998/003536 WO1998056355A1 (fr) 1997-06-12 1998-06-12 Preparations pharmaceutiques a liberation controlee contenant un inhibiteur de l'enzyme de conversion de l'angiotensine comme principe actif

Publications (2)

Publication Number Publication Date
NO996049D0 NO996049D0 (no) 1999-12-08
NO996049L true NO996049L (no) 2000-02-07

Family

ID=7832182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996049A NO996049L (no) 1997-06-12 1999-12-08 Farmasoeytisk preparat med kontrollert frigjoering, med ACE- inhibitor som aktiv ingrediens

Country Status (19)

Country Link
US (1) US6267990B1 (fr)
EP (1) EP0994696B1 (fr)
JP (1) JP2002504108A (fr)
CN (1) CN1260714A (fr)
AT (1) ATE259637T1 (fr)
AU (1) AU736357B2 (fr)
CA (1) CA2295013A1 (fr)
DE (2) DE19724696A1 (fr)
DK (1) DK0994696T3 (fr)
ES (1) ES2216296T3 (fr)
HU (1) HUP0002719A3 (fr)
IL (1) IL133442A0 (fr)
NO (1) NO996049L (fr)
NZ (1) NZ501726A (fr)
PL (1) PL192648B1 (fr)
SK (1) SK169999A3 (fr)
TR (1) TR199903069T2 (fr)
WO (1) WO1998056355A1 (fr)
ZA (1) ZA985142B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030042006A (ko) * 2000-10-16 2003-05-27 다이이찌 세이야꾸 가부시기가이샤 구강내 속붕괴성 의약 조성물 및 그의 제조방법
FR2818550B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Composition pharmaceutique solide thermoformable pour la liberation controle de perindopril
EP1499300B1 (fr) * 2002-04-29 2009-03-18 Supernus Pharmaceuticals, Inc. Preparations pharmaceutiques aux caracteristiques biologiques de liberation ameliorees
FR2841140B1 (fr) * 2002-06-24 2004-10-01 Servier Lab Microcapsules pour la liberation retardee et controlee du perindopril
CN1665490A (zh) * 2002-07-05 2005-09-07 特姆雷尔公司 控释组合物
WO2005046663A1 (fr) 2003-11-04 2005-05-26 Shire Laboratories, Inc. Composes d'ammonium quaternaire contenant des activateurs de la biodisponibilite
ES2359375T3 (es) 2003-11-04 2011-05-20 Supernus Pharmaceuticals, Inc. Formas de dosificación de dosis única diaria de trospio.
US20050203168A1 (en) * 2004-03-11 2005-09-15 The Regents Of The University Of Michigan Angiotensin converting enzyme inhibitor use for treatment and prevention of gastrointestinal disorders
ATE493973T1 (de) 2004-06-04 2011-01-15 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
KR100593795B1 (ko) 2004-10-12 2006-06-30 대원제약주식회사 안정성이 개선된 라미프릴을 포함하는 경구투여용 제제
US8080579B2 (en) * 2005-10-03 2011-12-20 The Regents Of The University Of Michigan Compositions and methods for treatment of inflammatory bowel disease
US7731604B2 (en) * 2006-10-31 2010-06-08 Taylor Made Golf Company, Inc. Golf club iron head
MX2011000909A (es) * 2008-07-30 2011-02-23 Panacea Biotec Ltd Composiciones de ramipril de liberacion modificada y usos de las mismas.
AU2015317469B2 (en) 2014-09-19 2018-03-15 The Procter & Gamble Company Pulsed release phenylephrine dosage forms
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2836447A1 (de) * 1978-08-19 1980-02-28 Boehringer Sohn Ingelheim Neue bunitrolol-retardform
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
AU591248B2 (en) * 1986-03-27 1989-11-30 Kinaform Technology, Inc. Sustained-release pharaceutical preparation
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5876754A (en) * 1992-01-17 1999-03-02 Alfatec-Pharma Gmbh Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
DE4431832A1 (de) * 1994-09-07 1996-03-14 Cordes Guenter Dr Arzneimittelzubereitung für ACE-Hemmer
DE19511131A1 (de) * 1995-03-27 1996-10-02 Basf Ag Mechanisch stabile feste Wirkstoffzubereitungsformen

Also Published As

Publication number Publication date
CN1260714A (zh) 2000-07-19
ES2216296T3 (es) 2004-10-16
JP2002504108A (ja) 2002-02-05
HUP0002719A3 (en) 2001-04-28
US6267990B1 (en) 2001-07-31
CA2295013A1 (fr) 1998-12-17
TR199903069T2 (xx) 2000-05-22
DE59810803D1 (de) 2004-03-25
DK0994696T3 (da) 2004-06-01
WO1998056355A1 (fr) 1998-12-17
PL192648B1 (pl) 2006-11-30
NZ501726A (en) 2001-09-28
SK169999A3 (en) 2000-07-11
HUP0002719A2 (hu) 2000-12-28
PL337279A1 (en) 2000-08-14
ZA985142B (en) 2000-01-12
AU8336898A (en) 1998-12-30
IL133442A0 (en) 2001-04-30
EP0994696A1 (fr) 2000-04-26
DE19724696A1 (de) 1998-12-24
AU736357B2 (en) 2001-07-26
EP0994696B1 (fr) 2004-02-18
NO996049D0 (no) 1999-12-08
ATE259637T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
NO996049L (no) Farmasoeytisk preparat med kontrollert frigjoering, med ACE- inhibitor som aktiv ingrediens
CA2354057A1 (fr) Comprime a liberation prolongee contenant un hydrocolloide et un ether de cellulose
PT888111E (pt) Composicao de multiplas unidades de dosagem de libertacao modificada.
DK0620731T3 (da) Farmaceutisk præparat i form af en bruse- og/eller henfaldstablet eller et instantgranulat samt fremgangsmåde til fremstilling deraf
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
BR0313424A (pt) Forma de dosagem e processo para a preparação de uma forma de dosagem
UY24288A1 (es) Procedimiento para la preparación de una composición de liberación retardada de paroxetina
MEP44308A (en) Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
NO951422L (no) Farmasöytiske sammensetninger for behandling av osteoporose
SE9603667D0 (sv) Pharmaceutical compositions
CA2238553A1 (fr) Composition abaissant le taux de cholesterol
EE03089B1 (et) Ibuprofeeni sisaldav kihisev ravimpreparaat ja selle valmistamise meetod
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
DE69628415D1 (de) Arzneimittel enthaltend monoaminooxidase-b-hemmer
WO2007010559A3 (fr) Nouvelle composition de forme dosifiee pharmaceutique a liberation modifiee comprenant un inhibiteur de l'enzyme cyclooxygenase
CA2378428A1 (fr) Utilisation d'antagonistes de cgrp et d'inhibiteurs de secretion cgrp servant a lutter contre les bouffees de chaleur de la menopause
CA2360300A1 (fr) Composition transdermique d'un agent antiemetique et preparation contenant cette composition
CA2202397A1 (fr) Compositions comprenant de l'acide dichloroacetique tamponne au carbonate/bicarbonate et procedes de traitement de troubles metaboliques et cardiovasculaires
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
NO993435L (no) Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon
AU1039400A (en) Opioid analgesic
WO1999042087A3 (fr) Compositions pharmaceutiques a liberation lente, a base de billes de chlorure de potassium et ayant une teneur elevee en principe actif
AU4400500A (en) Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application